LCE1C

gene
On this page

Also known as LEP3

Summary

LCE1C (late cornified envelope 1C, HGNC:29464) is a protein-coding gene on chromosome 1q21.3, encoding Late cornified envelope protein 1C (Q5T751). Precursors of the cornified envelope of the stratum corneum. It is a selective cancer dependency (DepMap: 60.0% of cell lines).

Predicted to be involved in keratinization.

Source: NCBI Gene 353133 — RefSeq curated summary.

At a glance

  • GWAS associations: 3
  • Clinical variants (ClinVar): 19 total
  • Cancer dependency (DepMap): dependent in 60.0% of screened cell lines
  • MANE Select transcript: NM_178351

Identifiers

Gene identifiers

FieldValue
HGNC IDHGNC:29464
Approved symbolLCE1C
Namelate cornified envelope 1C
Location1q21.3
Locus typegene with protein product
StatusApproved
AliasesLEP3
Ensembl geneENSG00000197084
Ensembl biotypeprotein_coding
OMIM612605
Entrez353133

Gene structure

Transcript identifiers

Ensembl transcripts: 2 — 2 protein_coding

ENST00000606576, ENST00000607093

RefSeq mRNA: 2 — MANE Select: NM_178351 NM_001276331, NM_178351

CCDS: CCDS1026

Canonical transcript exons

ENST00000607093 — 2 exons

ExonStartEnd
ENSE00003695306152804832152805498
ENSE00003918123152806601152806651

Expression profiles

Bgee: expression breadth broad, 99 present calls, max score 97.79.

FANTOM5 (CAGE): breadth tissue_specific, TPM avg 0.7289 / max 637.8096, expressed in 71 samples.

FANTOM5 promoters (1 alternative TSS)

Promoter IDTPM avgSamples expressed
145700.728971

Top tissues by expression

127 total, by Bgee expression score (0-100, higher = more expressed):

TissueAnatomy IDExpression scoreQuality
skin of legUBERON:000151197.79gold quality
zone of skinUBERON:000001497.20gold quality
skin of abdomenUBERON:000141696.30gold quality
lower esophagus mucosaUBERON:003583459.12gold quality
apex of heartUBERON:000209855.35gold quality
esophagus mucosaUBERON:000246952.20gold quality
gastrocnemiusUBERON:000138852.11gold quality
right adrenal gland cortexUBERON:003582749.53gold quality
muscle of legUBERON:000138348.53gold quality
fundus of stomachUBERON:000116048.28gold quality
popliteal arteryUBERON:000225048.05gold quality
tibial arteryUBERON:000761048.01gold quality
esophagusUBERON:000104347.00gold quality
heart left ventricleUBERON:000208446.40gold quality
sural nerveUBERON:001548846.36gold quality
subcutaneous adipose tissueUBERON:000219046.23gold quality
duodenumUBERON:000211446.18gold quality
right lobe of liverUBERON:000111444.75gold quality
adipose tissueUBERON:000101344.74gold quality
esophagogastric junction muscularis propriaUBERON:003584144.30gold quality
right atrium auricular regionUBERON:000663144.12gold quality
descending thoracic aortaUBERON:000234543.77gold quality
multicellular organismUBERON:000046843.63gold quality
adult mammalian kidneyUBERON:000008243.61gold quality
omental fat padUBERON:001041443.28gold quality
thoracic aortaUBERON:000151543.13gold quality
right hemisphere of cerebellumUBERON:001489043.00gold quality
cerebellumUBERON:000203742.90gold quality
cerebellar hemisphereUBERON:000224542.82gold quality
heartUBERON:000094842.70gold quality

Single-cell (SCXA)

Detected in 1 experiment(s), a significant marker in 0.

ExperimentMarker?Max mean expression
E-ANND-3no1.08

Regulation

Is transcription factor: no

miRNA regulators (miRDB)

26 targeting LCE1C, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):

miRNAMax scoreAvg scoremiRNA target_count
HSA-MIR-4728-5P99.8569.394718
HSA-MIR-6785-5P99.8268.684428
HSA-MIR-548AU-3P99.7068.221373
HSA-MIR-449B-3P99.2067.241047
HSA-MIR-429199.2068.882969
HSA-MIR-422A99.1865.83550
HSA-MIR-378A-3P98.4366.10548
HSA-MIR-378B98.4365.36573
HSA-MIR-378C98.4366.10548
HSA-MIR-378D98.4366.10548
HSA-MIR-378E98.4365.99551
HSA-MIR-378F98.4365.66554
HSA-MIR-378H98.4366.16545
HSA-MIR-378I98.4366.10548
HSA-MIR-7113-5P97.8867.331735
HSA-MIR-66597.6065.641781
HSA-MIR-64597.2866.30486
HSA-MIR-454096.9067.46473
HSA-MIR-212-5P96.8367.43950
HSA-MIR-34A-3P96.8067.70805
HSA-MIR-608596.5764.11621
HSA-MIR-6828-3P96.0667.611155
HSA-MIR-6823-3P95.4566.14704
HSA-MIR-2114-3P95.4566.11579
HSA-MIR-468395.2965.98631
HSA-MIR-6813-5P94.6864.20588

Functional genomics

DepMap (CRISPR cell-line fitness): dependent in 60.0% of screened cell lines.

Literature-anchored findings (GeneRIF, showing 3)

  • paper describing nomenclature changes and expression in range of tissues and in response to UV (PMID:15854049)
  • genetic polymorphism is associated with psoriasis vulgaris among Mongolians from Inner Mongolia (PMID:29397434)
  • Luciferase reporter assays using the promoter region of the LCE1C gene confirmed that the phosphorylations of TAp63-T46/T281 contributed to full transcriptional activation of the LCE1C gene. LCE1C interacted with protein arginine methyltransferase 5 (PRMT5) and translocated it from the nucleus to the cytoplasm. (PMID:29559659)

Cross-species orthologs

0 orthologs

Paralogs (1): LCE1B (ENSG00000196734)

Protein

Protein identifiers

Late cornified envelope protein 1CQ5T751 (reviewed: Q5T751)

Alternative names: Late envelope protein 3

All UniProt accessions (2): Q5T751, U3KQM4

UniProt curated annotations — full annotation on UniProt →

Function. Precursors of the cornified envelope of the stratum corneum.

Subunit / interactions. Interacts with CYSRT1.

Tissue specificity. Skin-specific. Expression was readily detected in adult trunk skin, adult arm skin, fetal skin, penal skin, vulva, esophagus and tongue. Not expressed in the cervix, rectum, lung, colon, or placenta.

Induction. By UVB.

Miscellaneous. Belongs to the LCE cluster present on 1q21.

Similarity. Belongs to the LCE family.

RefSeq proteins (2): NP_001263260, NP_848128* (*=MANE)

Domains & families (InterPro)

IDNameType
IPR028205LCEFamily

Pfam: PF14672

UniProt features (8 total): compositionally biased region 4, region of interest 2, chain 1, sequence variant 1

Structure

Experimental structures (PDB)

0 structures.

Predicted structure (AlphaFold)

ModelpLDDTFraction very-high
AF-Q5T751-F153.240.00

Function

Pathways and Gene Ontology

Reactome pathways

3 pathways

IDPathway
R-HSA-6809371Formation of the cornified envelope
R-HSA-1266738Developmental Biology
R-HSA-6805567Keratinization

MSigDB gene sets: 21 (showing top): GOBP_EPITHELIUM_DEVELOPMENT, GOBP_EPIDERMAL_CELL_DIFFERENTIATION, GOBP_EPIDERMIS_DEVELOPMENT, GOBP_KERATINIZATION, GOBP_SKIN_DEVELOPMENT, chr1q21, BRUINS_UVC_RESPONSE_VIA_TP53_GROUP_B, ZWANG_TRANSIENTLY_UP_BY_2ND_EGF_PULSE_ONLY, REACTOME_KERATINIZATION, REACTOME_FORMATION_OF_THE_CORNIFIED_ENVELOPE, GOBP_KERATINOCYTE_DIFFERENTIATION, GOBP_EPITHELIAL_CELL_DIFFERENTIATION, ZNF146_TARGET_GENES, MIR7113_5P, MIR4540

GO Biological Process (2): keratinization (GO:0031424), epidermis development (GO:0008544)

GO Molecular Function (1): protein binding (GO:0005515)

GO Cellular Component (0):

Reactome top-level categories

Rollup of top-2 pathways:

CategoryPathways
Keratinization1
Developmental Biology1

GO top-level categories

Rollup of top GO terms by namespace:

CategoryTerms
keratinocyte differentiation1
multicellular organismal process1
tissue development1
binding1

Protein interactions and networks

STRING

288 interactions, top by confidence (×1000):

Protein AProtein BPartner UniProtScore
LCE1CLCE1BQ5T7P3862
LCE1CLCE1EQ5T753817
LCE1CLCE2DQ5TA82780
LCE1CLCE2AQ5TA79764
LCE1CLCE1AQ5T7P2761
LCE1CLCE3EQ5T5B0757
LCE1CLCE2CQ5TA81756
LCE1CLCE1DQ5T752720
LCE1CLCE1FQ5T754695
LCE1CLCE3DQ9BYE3664
LCE1CLCE2BO14633623
LCE1CSPRR2AP35326621
LCE1CSPRR2DP22532615
LCE1CLCE3CQ5T5A8601
LCE1CLCE6AA0A183597

IntAct

208 interactions, top by confidence:

ABTypeScore
KRTAP10-5LCE1Cpsi-mi:“MI:0915”(physical association)0.560
LCE1CKRTAP4-5psi-mi:“MI:0915”(physical association)0.560
LCE1CTRIM42psi-mi:“MI:0915”(physical association)0.560
LCE1CCHIC2psi-mi:“MI:0915”(physical association)0.560
KRTAP12-4LCE1Cpsi-mi:“MI:0915”(physical association)0.560
LCE1CKRTAP9-3psi-mi:“MI:0915”(physical association)0.560
KRTAP10-8LCE1Cpsi-mi:“MI:0915”(physical association)0.560
LCE1CLCE3Apsi-mi:“MI:0915”(physical association)0.560
LCE1Cpsi-mi:“MI:0915”(physical association)0.560
LCE1CVASNpsi-mi:“MI:0915”(physical association)0.560
LCE1CNTN4psi-mi:“MI:0915”(physical association)0.560
KRTAP12-1LCE1Cpsi-mi:“MI:0915”(physical association)0.560
LCE1CLCE5Apsi-mi:“MI:0915”(physical association)0.560
LCE1Cpsi-mi:“MI:0915”(physical association)0.560
VWC2LCE1Cpsi-mi:“MI:0915”(physical association)0.560
KRTAP12-3LCE1Cpsi-mi:“MI:0915”(physical association)0.560
LCE1CLCE1Bpsi-mi:“MI:0915”(physical association)0.560
LCE1CADAMTSL4psi-mi:“MI:0915”(physical association)0.560
LCE1CLCE2Cpsi-mi:“MI:0915”(physical association)0.560
LCE1CSPRED2psi-mi:“MI:0915”(physical association)0.560
POU4F2LCE1Cpsi-mi:“MI:0915”(physical association)0.560
LCE1CKRTAP4-12psi-mi:“MI:0915”(physical association)0.560
LCE1CKRTAP4-2psi-mi:“MI:0915”(physical association)0.560
LCE1CGUCD1psi-mi:“MI:0915”(physical association)0.560
KRTAP5-9LCE1Cpsi-mi:“MI:0915”(physical association)0.560
LCE1CKRTAP5-6psi-mi:“MI:0915”(physical association)0.560
LCE2BLCE1Cpsi-mi:“MI:0915”(physical association)0.560
LCE1CKRTAP5-3psi-mi:“MI:0915”(physical association)0.560
LCE1CLCE1Apsi-mi:“MI:0915”(physical association)0.560

BioGRID (76): LCE1C (Two-hybrid), LCE1C (Two-hybrid), LCE1C (Two-hybrid), LCE1C (Two-hybrid), LCE1C (Two-hybrid), LCE1C (Two-hybrid), LCE1C (Two-hybrid), LCE1C (Two-hybrid), LCE1C (Two-hybrid), LCE1C (Two-hybrid), LCE1C (Two-hybrid), LCE1C (Two-hybrid), LCE1C (Two-hybrid), LCE1C (Two-hybrid), LCE1C (Two-hybrid)

ESM2 similar proteins: A0A286YEV6, A0A286YEX9, A0A286YEY9, A0A286YF01, A0A286YF46, A0A286YF60, A0A286YF77, A0A286YFB4, A0A286YFG1, O14633, P02438, P05687, P05688, P08131, P08175, P0DSO2, P20730, Q01642, Q01643, Q01644, Q01645, Q07627, Q3LI58, Q3LI59, Q3V2C1, Q5T750, Q5T751, Q5T752, Q5T754, Q5TA77, Q5TA78, Q5TA79, Q5TA81, Q5TA82, Q5TCM9, Q9BQ66, Q9BYP8, Q9BYQ5, Q9BYQ6, Q9BYQ7

Diamond homologs: Q5T751, Q5T752, Q5T753, Q5T754, Q5T7P2, Q5T7P3, Q5T5A8, Q5TA79

SIGNOR signaling

0 interactions.

Enriched among interaction partners

Reactome pathways and GO biological processes over-represented among this gene’s 64 IntAct physical interaction partners (hypergeometric vs the genome-wide background, BH-FDR, gene-set size 15–500, ranked by fold). A functional readout of the neighbourhood — distinct from this gene’s own memberships above, and biased toward well-studied / hub proteins, so read it as themes rather than proof.

Reactome pathways:

PathwayPartnersFoldFDR
Keratinization3037.1×2e-40
Formation of the cornified envelope1223.4×3e-12

GO biological processes:

GO termPartnersFoldFDR
hair cycle595.5×3e-07
keratinization1362.1×4e-18

Disease & clinical

Clinical variants and AI predictions

ClinVar

19 variants total. Per-class counts are floors (≥ shown; pagination cap):

ClassificationCount (floor)
Pathogenic0
Likely pathogenic0
Uncertain significance15
Likely benign2
Benign2

Top pathogenic / likely-pathogenic (0)

SpliceAI

248 predictions. Top by Δscore:

VariantEffectΔscore
1:152805433:A:ACdonor_gain0.9400
1:152805434:C:CCdonor_gain0.9400
1:152805264:C:Adonor_gain0.8800
1:152805375:G:Cdonor_gain0.8600
1:152805421:A:ACdonor_gain0.8600
1:152805422:C:CCdonor_gain0.8600
1:152805452:CTG:Cdonor_gain0.8600
1:152805263:T:TAdonor_gain0.8500
1:152805374:A:ACdonor_gain0.8500
1:152805230:A:ACdonor_gain0.8400
1:152805231:C:CCdonor_gain0.8400
1:152805282:C:Adonor_gain0.8400
1:152805258:C:CTdonor_gain0.8200
1:152805423:T:Cdonor_gain0.8200
1:152805451:A:ACdonor_gain0.8200
1:152805452:C:CCdonor_gain0.8200
1:152805231:CGG:Cdonor_gain0.8100
1:152805231:CGGCG:Cdonor_gain0.8100
1:152805259:C:CTdonor_gain0.8000
1:152805332:T:TAdonor_gain0.7800
1:152805435:T:Cdonor_gain0.7600
1:152805257:G:Cdonor_gain0.7300
1:152805281:T:TAdonor_gain0.7300
1:152804865:CG:Cacceptor_gain0.7100
1:152805222:TGGG:Tdonor_gain0.7000
1:152805345:C:CCacceptor_gain0.6700
1:152804863:CACG:Cacceptor_gain0.6600
1:152805447:TGG:Tdonor_gain0.6600
1:152804867:C:CCacceptor_gain0.6500
1:152805087:T:TAdonor_gain0.6500

AlphaMissense

771 scored. Top likely-pathogenic:

VariantProtein changeam_pathogenicity
1:152805461:G:CS6R0.843
1:152805461:G:TS6R0.843
1:152805463:T:GS6R0.843
1:152805451:A:GC10R0.797
1:152805472:A:GC3R0.793
1:152805245:G:CS78R0.785
1:152805245:G:TS78R0.785
1:152805247:T:GS78R0.785
1:152805467:C:AQ4H0.785
1:152805467:C:GQ4H0.785
1:152805449:G:CC10W0.776
1:152805256:A:GC75R0.765
1:152805127:A:GC118R0.741
1:152805422:C:AK19N0.732
1:152805422:C:GK19N0.732
1:152805434:C:AK15N0.720
1:152805434:C:GK15N0.720
1:152805272:A:CS69R0.718
1:152805272:A:TS69R0.718
1:152805274:T:GS69R0.718
1:152805410:C:AK23N0.717
1:152805410:C:GK23N0.717
1:152805433:A:GC16R0.707
1:152805394:A:GC29R0.706
1:152805458:C:AQ7H0.706
1:152805458:C:GQ7H0.706
1:152805125:G:CC118W0.703
1:152805395:C:AK28N0.701
1:152805395:C:GK28N0.701
1:152805380:A:CC33W0.697

dbSNP variants (sampled 300 via entrez): RS1000140142 (1:152808227 T>C,G), RS1001337437 (1:152806166 G>T), RS1002178744 (1:152806482 G>C), RS1003163145 (1:152807155 A>G,T), RS1003416090 (1:152807446 C>T), RS1003446431 (1:152808383 A>C), RS1003906538 (1:152808639 C>T), RS1005220640 (1:152808361 G>A,C), RS1005433474 (1:152808404 A>G), RS1006103974 (1:152805593 T>A,C,G), RS1006512045 (1:152804817 A>T), RS1006691627 (1:152804333 A>G), RS1006741174 (1:152807225 T>C), RS1007407107 (1:152804689 C>T), RS1008862118 (1:152806499 A>G)

Disease associations

OMIM: gene MIM:612605 | disease phenotypes:

GenCC curated gene-disease

Mondo (0):

Orphanet (0):

HPO phenotypes

0 total (0 of 0 shown, HPO-id order):

GWAS associations

3 associations (top):

StudyTraitp-value
GCST007564_25Asthma or allergic disease (pleiotropy)5.000000e-09
GCST008916_82Asthma5.000000e-27
GCST008916_92Asthma6.000000e-16

Drugs & pharmacology

Drug and pharmacology data

Is drug target: no

PharmGKB: 1 entry (VIP=true, CPIC=false)

CTD chemical–gene interactions

19 total (human), top 19 by PubMed support.

ChemicalActions (top 5)PubMed papers
propionaldehydeincreases expression1
sodium arsenatedecreases expression, increases abundance1
butyraldehydeincreases expression1
tobacco tardecreases reaction, increases expression1
diallyl disulfidedecreases reaction, increases expression1
nutlin 3affects cotreatment, increases expression1
Resveratrolaffects cotreatment, decreases expression1
Arsenicdecreases expression, increases abundance1
Benzo(a)pyreneincreases methylation1
Cadmiumdecreases expression, increases abundance1
Camptothecinincreases expression1
Dactinomycinaffects cotreatment, increases expression1
Formaldehydedecreases expression1
Plant Extractsaffects cotreatment, decreases expression1
Tetrachlorodibenzodioxinincreases expression1
Aflatoxin B1decreases methylation1
Sodium Seleniteincreases expression1
Cadmium Chloridedecreases expression, increases abundance1
Lactic Aciddecreases expression1

Clinical trials (associated diseases)

0 trials via MONDO — disease-level, not drug-specific.

No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.